
Validea's Peter Lynch P/E/Growth Investor model assigned Centene Corp (CNC), a large-cap healthcare facilities stock, a 72% rating, which is below the 80% threshold typically indicating investment interest. While CNC passed tests for PEG ratio, EPS, and Total Debt/Equity, and showed neutral free cash flow and net cash position, it notably failed the Inventory to Sales criterion, impacting its overall fundamental and valuation score.
Centene Corp (CNC), a large-cap value stock in the Healthcare Facilities sector, presents a mixed fundamental profile according to Validea's Peter Lynch-based P/E/Growth model, scoring 72%. This rating is below the 80% threshold that typically indicates investment interest from the strategy. The company demonstrates strengths in key areas, passing tests for its Yield Adjusted P/E to Growth (PEG) ratio, Earnings Per Share (EPS), and a favorable Total Debt/Equity ratio, suggesting it is reasonably priced relative to its growth and maintains a manageable leverage profile. However, these positive factors are counterbalanced by a notable 'FAIL' on the Inventory to Sales metric, which is a significant weakness under this specific analytical framework. Additionally, the company's Free Cash Flow and Net Cash Position are rated as 'NEUTRAL', indicating they are neither a source of strength nor a significant concern at present. The overall assessment points to a company with some attractive GARP characteristics that is ultimately held back from a strong endorsement by specific operational and cash-related metrics.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment